The positive opinion for use of Cosentyx either alone or in combination with methotrexate has been given for the juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) The post Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions appeared first on Pharmaceutical Business review.

Proceeds from the financing round will be used by the company to advance Inceptor Bio’s CAR-T lead programme to a Phase I clinical trial as well as continue The post Inceptor Bio raises $37m from Series A to advance CAR-T lead programme appeared first on Pharmaceutical Business review.

Anthracyclines just as doxorubicin are the initial treatment of choice for TNBC. Although doxorubicin has reduced breast cancer mortality significantly, it is linked with a dose-dependent cumulative and The post NovoMedix gets NIH grant to advance NMX1 in TNBC appeared first on Pharmaceutical Business review.

SIGA said the drug could also be used in the treatment of monkeypox.

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...

PharmaLeaders is pleased to provide our subscribers with a special offer from our webinar partner and presenter, Collaborative Marketing Solutions (CMS). Get your own Marketing Tech Workshop for Life Sciences:  Full Day or Half Day Sessions Facilitated Exercises & Group Breakout Sessions Customer Segmentation Project Prioritization Project Implementation Roadmap Follow-on Kick-off Call